AAAlaettin Arslan

Alaettin Arslan

*This is an algorithmically generated author record based on publicly available information.

Alaettin Arslan has a total of 95 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prognostic evaluation of sarcopenia with radiological and laboratory parameters in geriatric head and neck cancer patients

    by Hatice Basaran Goksen, Tugba Uylar Seber, Alaettin Arslan

    Background The study aimed to investigate the effect of sarcopenia on survival by evaluating it with pre-treatment and post-treatment radiological and pre-treatment laboratory parameters in patients in the geriatric age group (≥ 65) who were diagnosed with head and neck cancer and received radiotherapy. Methods 74 patients who were diagnosed and received radiotherapy (RT) at Kayseri City Training and Research Hospital between 2015 and 2024 were included in the study. The muscle areas at the C3 vertebra level were measured from the pre-treatment and post-treatment computed tomography images of the patients. These muscle area measurements were translated into L3 vertebral muscle area. Results The median overall survival (mOS) of the patients was 36 months. Skeletal muscle index (SMI) values were calculated and evaluated in three categories as pre-treatment (SMIpre), post-treatment (SMIpost) and pre-treatment and post-treatment difference (SMIdiff). While the mOS value of the SMIdiff < 0.46 group could not be accessed, the mOS value of the > 0.46 group was 59 months (p = 0.074). In multivariate Cox regression analysis, independent factors affecting survival were determined as SMIdiff, lymph node involvement, and RT intention (p values: 0.027, 0.006, and 0.047 respectively). Conclusions The importance of nutrition both before and during treatment in this age group, which is more prone to malnutrition, is supported by our study, which has a limited number of patients. To the best of our knowledge, the effect of SMIdiff value on survival before and after treatment and the evaluation of PNI in patients with geriatric head and neck cancer are shown for the first time in the literature.

  • Open Access

    Comparison of inflammatory and nutritional markers obtained at the time of diagnosis in patients diagnosed with renal cell carcinoma

    by Hatice Basaran Goksen, Alaettin Arslan

    This study aimed to compare the prognostic significance of inflammatory and nutritional parameters, calculated based on hemogram and biochemical values at the time of diagnosis, in patients diagnosed with renal cell carcinoma (RCC). A total of 120 patients diagnosed with RCC and receiving diagnosis and/or treatment at our center were included in the study. Among the inflammatory and nutritional parameters, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), prognostic nutritional index (PNI), modified Glasgow prognostic score (mGPS), and Memorial Sloan Kettering prognostic score (MPS) were calculated and analyzed. The most common pathological subtype was the clear cell variant (69.2%). 25.8% of the patients were at the metastatic stage. Univariate Cox regression analysis revealed that tumor size, tumor grade, sex, stage, presence of metastasis, number of metastases, IVC involvement, history of radiotherapy (RT), hemoglobin, NLR, PLR, PNI, albumin, C-reactive protein (CRP), MPS, and mGPS had a significant impact on survival. Furthermore, stage, number of metastases, and PNI were identified as independent prognostic factors for survival. When clinical parameters were excluded from the analysis, NLR, LDH, and mGPS emerged as independent prognostic factors for survival.As demonstrated by the results of the multivariate analysis, stage, number of metastases, and PNI were found to be more influential independent prognostic factors. This study suggests that nutritional parameters have greater prognostic value than inflammatory markers in RCC, and that a simple nutritional scoring system performed at the time of diagnosis may provide improved prognostic accuracy. Additionally, our findings indicate that the MPS, which was evaluated for the first time in RCC in this study, also has prognostic significance, and it may potentially become an independent prognostic marker in future studies with larger patient populations.


  • Two-arm study of sarcopenia in geriatric patients with high-grade glial tumors: temporal muscle thickness and prognostic nutritional index

    by Hatice Basaran Goksen, Alaettin Arslan, Hasan Erdogan

    Purpose To analyze the prognostic significance of temporal muscle thickness (TMT) and prognostic nutritional index (PNI) in the assessment of sarcopenia in patients diagnosed with glioblastoma multiforme (GBM) in the geriatric age group. Methods This study included a total of 50 patients (≥65 years of age) receiving radiotherapy (RT)/radio-chemotherapy (RCT) at Kayseri City Education and Research Hospital. We calculated TMT from cranial magnetic resonance imaging (MRI) at the time of diagnosis and PNI from laboratory measurements. To determine the cut-off values, we used the ROC analysis. The combined group (CG) was formed according to TMT and PNI. Results Median overall survival (OS) was 5 months. OS for those with TMT < 6.75 cm and ≥ 6.75 cm was 5 months and 11 months, respectively (p < 0.001). OS for those with PNI < 48.87 cm and ≥ 48.87 cm was 5 months and 11 months, respectively (p = 0.026). Survival analysis showed a dramatic difference in CG between groups 1 and 4 (16 months vs. 4 months, p < 0.001). Correlations were observed between TMT and age, excision type and OS (r = 0.406 p = 0.003, r = 0.346 p = 0.014, r = 0.345 p = 0.014). Univariate Cox regression analysis showed that age, excision type, diagnosis type, RT history, initial tumor volume (ITV), TMT, PNI, CG, and albumin had an effect on survival (p values 0.017, <0.001, <0.001, <0.001, 0.011, <0.001, 0.041, 0.001, and 0.018, respectively). Multivariate Cox regression analysis showed that excision type, RT history, ITV, albumin, and CG were independent factors affecting survival (p values 0.007, 0.05, 0.005, 0.029, and 0.014, respectively). Conclusion Although both parameters individually have a prognostic effect in geriatric GBM patients, their combined effect as a single parameter has a much stronger impact on prognosis.


  • PROGNOSTIC EVALUATION OF GERIATRIC NUTRITIONAL RISK INDEX IN GERIATRIC PATIENTS WITH HEAD AND NECK CANCER

    by Hatice Başaran Göksen, Mahiya Özel, Alaettin Arslan

    Introduction: The aim of this study is to evaluate the prognostic effect of Geriatric Nutritional Index screening performed before oncological treatments in geriatric age group locally advanced head and neck cancer patients. Materials and Method: Eighty-two patients diagnosed at geriatric age between January 2016 and November 2024 were included in the study. All patients had locally advanced disease (Stage 3 and Stage 4 disease). Age, tumor diameter, body mass index, Geriatric Nutritional Index, neutrophillymphocyte ratio , platelet-lymphocyte ratio , c-reactive protein, hemoglobin, lactate dehydrogenase, and primary tumor standardized uptake value maximum (pSUVmax) numerical variables were analyzed. Geriatric Nutritional Index was divided into four subgroups; patients with> 98 were considered as no risk for malnutrition, patients with≤ 98 and ≥ 92 were considered as mild risk, patients with< 92 and ≥ 82 considered as moderate risk and patients with< 82 considered as high risk. Results: The median overall survival of the patients was 16.5 months. The median overall survival of patients with severe-risk Geriatric Nutritional Index was 5 months, while the median overall survival of patients with no-risk group was 44 months (p=0.067). In multivariate Coxregression analysis Geriatric Nutritional Index was identified as the single factor independently affecting survival (p: 0.032). Conclusion: Geriatric Nutritional Index gave a comparable result with clinical and laboratory parameters known to have an effect on prognosis. Especially in geriatric patients, who are a group vulnerable to neglect in terms of treatment, a practical evaluation and Geriatric Nutritional Index calculation before oncological process planning may be guiding in terms of creating a survival prediction and deciding on the treatment process. Keywords: Geriatrics; Head and Neck Neoplasms; Nutrition Assessment; Mortality; Aged.

  • Factors on development and severity of acute radiodermatitis: prospective single-center study

    by Gonca Altinişik İnan, Alaettin Arslan, İpek Pınar Aral, Suheyla Aytaç Arslan

    Aim: Although prior literature has examined the treatment and patient-associated factors affecting the development and severity of acute radiodermatitis, there are relatively few prospective studies evaluating both. This study was prospectively designed to evaluate factors affecting the development and extent of radiation-induced acute skin toxicity called radiodermatitis (RD). Material and Method: A total of 63 patients who underwent radiotherapy (RT) in Ankara Atatürk Research and Education Hospital between July 2017 and October 2018 were evaluated. Patients’ demographic status, disease/treatment details, hemoglobin, ferritin, folic acid, Vit B12, and hemoglobin A1c values were recorded. The development and grade of RD were evaluated weekly by the same radiation oncologist using the Radiation Therapy Oncology Group (RTOG) radiation toxicity guideline. Results: There was no significant relationship between the development of any degree of RD and gender, concomitant chemotherapy (CT), pre-RT CT, comorbid disease, RT technique and blood parameters (Hb, Hba1c, ferritin, folic acid and B12). The development of grade 2-3 RD was significantly affected by the number of operations (p=0.032) and total dose of RT (p=0.008). In patients with grade 2/3 RD, the RT dose at which RD first appeared was 20 Gy (range, 14-36); in patients with grade 1 RD, this value was 32 Gy (range, 16-56) (p=0.018). Conclusion: There is no significant relationship between the development of acute radiodermatitis and Hba1c, hemoglobin, ferritin, B12 and folic acid levels. There was a significant correlation between grade of RD and repeated surgery, increase in total RT dose and early onset of RD.


  • Temel Onkoloji

    by Melike Ordu, Melike Nalbant, Serhat Toprak, Ezgi Hacıhasanoğlu, Esra Çobankent Aytekin, Mehtap Eroğlu, Ebru Altındal Susem, Murat Keser, Ezgi Işıl Turhan, Kıvılcım Eren Erdoğan, et al.

    Onkoloji alanındaki tüm dünyanın yakın takip ettiği bilimsel gelişmeler ışığında günümüzde artık sistemik kemoterapi gibi konvansiyonel tedaviler yerlerini büyük ölçüde immünoterapi, moleküler hedefli ilaçlar ve gen tedavilerine bırakmaya başlamıştır. Bu tedavi stratejilerinin geliştirilmesi, yeni ilaçların keşifleri ve mevcut ilaçlara karşı gelişen direnç mekanizmalarının anlaşılması ve tümörlerin detaylı kimliklendirilmelerinin önemi tartışılmaz bir gerçek ve gereklilik haline gelmiştir. Moleküler ve genetik temelli çalışmalar bize bu imkanları sağlama konusunda çok önemli katkılar sağlamaktadır.

  • Open Access

    Factors on Development and Severity of Acute Radiodermatitis: Prospective Single-Centre Study

    by Gonca Altınışık İnan, Alaettin Arslan, İpek Pınar Aral, Suheyla Aytaç Arslan

    Background: Although prior literature has examined the treatment and patient-associated factors affecting the development and severity of acute radiodermatitis, there are relatively few prospective studies evaluating both.Aims and Objectives: This study was prospectively designed to evaluate factors affecting the development and extent of radiation-induced acute skin toxicity called radiodermatitis (RD).Materials and Methods: A total of 63 patients who underwent radiotherapy (RT) in Ankara Atatürk Research and Education Hospital between 20.06.2016 and 21.10.2017 were evaluated. Patients' demographic status, disease/treatment details, anemia, and diabetic profile tests’ (hemoglobin, ferritin, folic acid, Vit B12, and hemoglobin A1c) were recorded. The development and the degree of RD were assessed weekly by treating radiation oncologists using Radiation Therapy Oncology Group (RTOG) radiation toxicity manual.Results: The development of any grade of RD was not significantly affected by gender, concurrent chemotherapy (CT), pre-RT CT, the comorbid disease, RT technic, and anemia & diabetic profile tests’ values. The development of grade 2-3 RD was significantly affected by the number of operations (p = 0.032) and total dose of RT (p = 0.008). The starting dose for RD is 20 Gy in patients with grade 2-3 RD and 32 Gy in patients with grade 1 RD (p = 0.018).Conclusion: There was no significant relationship between RD and anemia/diabetic profile parameters. The severity of RD was associated with recurrent surgical intervention, total dose, and early onset of RD.

  • Comparison of clinical features and the impact of reproductive factors on by age at diagnosis young and elderly breast cancer patients in the middle Anatolian region of Turkey

    by S K Eren, A Arslan, E Ç Çalışkan, E Akay, N Özhan, Ö Topuz, T Ertan

    Reproductive risk factors have been shown to influence breast cancer etiology for women of different origin worldwide; most studies in young/older patients have been limited to analyzing survival or tumor characteristics within their age group. This study aimed to compare the clinicopathological characteristics, treatment regimens, survival outcomes, and the impact of reproductive risk factors on young and elderly breast cancer patients. The data were collected retrospectively between October 2015 and March 2021, where 77 young patients (≤ 40 years) and 107 elderly patients (>65 years) were included out of a total of 567 patients undergoing treatment at Kayseri City Training and Research Hospital General Surgery Clinic, Turkey. Logistic regression analysis was performed to assess the impact of risk factors according to age. Luminal-like tumors were in the majority in both age groups; there was no difference in diagnostic stages and survival between groups. The nulliparity ratio, total breastfeeding duration, number of biological children, first full-term pregnancy age, body mass index (BMI), and breast density distribution were significantly statistically different between groups. According to the multiple binary logistic regression analysis results for age, the most significant factors with risk effects were variables age of menarche OR= 3.36 (95% CI: 1.44-7.86) and child number OR= 2.58 (95% CI: 1.75-3.79), respectively. The importance of looking at the impact of different risk factors on breast cancer risk lies in the potential to develop valid risk prediction models that can allow targeted screening and preventive interventions for high-risk women. By identifying more influential risk factors in different geographical profiles, risk-based screening, and targeted prevention efforts can be encouraged, and these factors can be included in risk prediction models.


  • Open Access

    Assessing Clinicopathological Features and Prognosis of Triple-Negative Breast Cancer Patients: A Single-Center Study in Turkey

    by Saliha Karagöz Eren, Alaettin Arslan, Ebru Akay, Nail Özhan, Yunus Dönder

    Background: Triple-negative breast cancer (TNBC) is defined as tumors without estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression. This cancer is associated with higher rates of recurrence risk when compared to other subtypes of breast cancers. In this study, we aimed to explore the basic clinicopathological characteristics, prognosis, and recurrence patterns of TNBC patients. Methods: In the current study, forty-five TNBC female patients operated on for breast cancer in the General Surgery Clinic of Kayseri City Training and Research Hospital between 2016 and 2021 were included and retrospectively evaluated. Results: The percentage of TNBC was 12% of the 502 breast cancer patients who could access all three pieces of receptor information. The mean age of the patients was 58.9±15.2 years (27-90), and the mean BMI was 30.4±5.17 (21.5-40.6). It was observed that the most common histological subtype was invasive ductal carcinoma, and at the time of diagnosis, 11 patients were stage 1 (24.4%), 31 patients were stage 2 (68.8%), 2 patients were stage 3 (4.4%), and 1 patient was stage 4 (2.2%). During the follow-up period, 11 patients (24,4%) developed metastasis and the most common sites were the brain and bones. The mean time from diagnosis to metastasis was 20.7±5.75 (12-29) months. The 3-year disease-free survival was 62%, and the 3-year overall survival (OS) was 70%. Conclusion: TNBCs are cancers with varying prevalence, poor prognosis, and limited treatment alternatives. The prevalence of TNBC in our center was found to be lower than the literature rates and consistent with the literature, the lymph node stage was related to poor OS and disease free survival (DFS).